Abstract
The concept that genetic factors contribute to the complex trait of suicidal behaviour has stimulated much work aimed at identifying susceptibility genes. So far molecular genetic studies focused on the serotonergic pathway as the intent to die and the lethality of suicide acts were related to the serotonergic system. Two genes have so far emerged as being involved in the vulnerability for suicidality: first, the intronic polymorphisms (A218C or A779C) of the tryptophan hydroxylase 1 (TPH1) gene, which was suggested as a quantitative risk factor for suicidal behaviour; second, the insertion/deletion polymorphism of the serotonin transporter gene (5-HTTLPR), which does not seem to be involved in general suicidal behaviour, but in violent and repeated suicide attempts. The data have further shown that the MAOA gene, which is consistently associated with impulsive-aggressive personality traits, is not related to suicide but might induce violent methods in subjects with other suicide risk factors. Predominantly negative were the findings with any type of the serotonin receptors and inconsistent with catecholamine-synthesizing and -metabolizing enzymes or with the dopaminergic receptors. This paper reviews the status of current knowledge in this area, points to the weakness of the investigations and presents new approaches beyond the serotonergic system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
World Health Organization. World Health Report 2000. Health Systems: Improving Performance. World Health Organization: Geneva, 2000.
Phillips MR, Li X, Zhang Y . Suicide rates in China, 1995–1999. Lancet 2002; 359: 835–840.
Bertolote JM, Fleischmann A . Suicidal behavior prevention: WHO perspectives on research. Am J Med Genet C Semin Med Genet 2005; 133: 8–12.
Suominen K, Isometsa E, Suokas J, Haukka J, Achte K, Lonnqvist J . Completed suicide after a suicide attempt: a 37-year follow-up study. Am J Psychiatry 2004; 161: 562–563.
Fleischmann A, Bertolote JM, Belfer M, Beautrais A . Completed suicide and psychiatric diagnoses in young people: a critical examination of the evidence. Am J Orthopsychiatry 2005; 75: 676–683.
Marusic A . History and geography of suicide: could genetic risk factors account for the variation in suicide rates? Am J Med Genet C Semin Med Genet 2005; 133: 43–47.
Mann JJ . A current perspective of suicide and attempted suicide. Ann Intern Med 2002; 136: 302–311.
Mann JJ, Apter A, Bertolote J, Beautrais A, Currier D, Haas A et al. Suicide prevention strategies: a systematic review. JAMA 2005; 294: 2064–2074.
Zimmerman M, Lish JD, Lush DT, Farber NJ, Plescia G, Kuzma MA . Suicidal ideation among urban medical outpatients. J Gen Intern Med 1995; 10: 573–576.
Courtet P, Jollant F, Castelnau D, Buresi C, Malafosse A . Suicidal behavior: relationship between phenotype and serotonergic genotype. Am J Med Genet C Semin Med Genet 2005; 133: 25–33.
Leboyer M, Slama F, Siever L, Bellivier F . Suicidal disorders: a nosological entity per se? Am J Med Genet C Semin Med Genet 2005; 133: 3–7.
Dumais A, Lesage AD, Alda M, Rouleau G, Dumont M, Chawky N et al. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry 2005; 162: 2116–2124.
Mann JJ . Neurobiology of suicidal behaviour. Nat Rev Neurosci 2003; 4: 819–828.
Baud P . Personality traits as intermediary phenotypes in suicidal behavior: genetic issues. Am J Med Genet C Semin Med Genet 2005; 133: 34–42.
Turecki G . Dissecting the suicide phenotype: the role of impulsive-aggressive behaviours. J Psychiatry Neurosci 2005; 30: 398–408.
Brent DA, Mann JJ . Family genetic studies, suicide, and suicidal behavior. Am J Med Genet C Semin Med Genet 2005; 133C: 13–24.
Roy A . Genetic and biologic risk factors for suicide in depressive disorders. Psychiatr Q 1993; 64: 345–358.
Statham DJ, Heath AC, Madden PA, Bucholz KK, Bierut L, Dinwiddie SH et al. Suicidal behaviour: an epidemiological and genetic study. Psychol Med 1998; 28: 839–855.
Roy A, Segal NL, Sarchiapone M . Attempted suicide among living co-twins of twin suicide victims. Am J Psychiatry 1995; 152: 1075–1076.
McGuffin P, Marusic A, Farmer A . What can psychiatric genetics offer suicidology? Crisis 2001; 22: 61–65.
Asberg M, Traskman L, Thoren P . 5-HIAA in the cerebrospinal fluid. A biochemical suicide predictor? Arch Gen Psychiatry 1976; 33: 1193–1197.
Mann JJ, Malone KM . Cerebrospinal fluid amines and higher-lethality suicide attempts in depressed inpatients. Biol Psychiatry 1997; 41: 162–171.
Virkkunen M, Goldman D, Nielsen DA, Linnoila M . Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J Psychiatry Neurosci 1995; 20: 271–275.
Mann JJ, Henteleff RA, Lagattuta TF, Perper JA, Li S, Arango V . Lower 3H-paroxetine binding in cerebral cortex of suicide victims is partly due to fewer high affinity, non-transporter sites. J Neural Transm 1996; 103: 1337–1350.
Arango V, Underwood MD, Gubbi AV, Mann JJ . Localized alterations in pre- and postsynaptic serotonin binding sites in the ventrolateral prefrontal cortex of suicide victims. Brain Res 1995; 688: 121–133.
Malone KM, Corbitt EM, Li S, Mann JJ . Prolactin response to fenfluramine and suicide attempt lethality in major depression. Br J Psychiatry 1996; 168: 324–329.
Meyer JH, McMain S, Kennedy SH, Korman L, Brown GM, DaSilva JN et al. Dysfunctional attitudes and 5-HT2 receptors during depression and self-harm. Am J Psychiatry 2003; 160: 90–99.
Ordway GA, Widdowson PS, Smith KS, Halaris A . Agonist binding to alpha 2-adrenoceptors is elevated in the locus coeruleus from victims of suicide. J Neurochem 1994; 63: 617–624.
Ordway GA, Smith KS, Haycock JW . Elevated tyrosine hydroxylase in the locus coeruleus of suicide victims. J Neurochem 1994; 62: 680–685.
Biegon A, Fieldust S . Reduced tyrosine hydroxylase immunoreactivity in locus coeruleus of suicide victims. Synapse 1992; 10: 79–82.
Hurd YL, Herman MM, Hyde TM, Bigelow LB, Weinberger DR, Kleinman JE . Prodynorphin mRNA expression is increased in the patch vs matrix compartment of the caudate nucleus in suicide subjects. Mol Psychiatry 1997; 2: 495–500.
Sumiyoshi T, Stockmeier CA, Overholser JC, Thompson PA, Meltzer HY . Dopamine D4 receptors and effects of guanine nucleotides on [3 H]raclopride binding in postmortem caudate nucleus of subjects with schizophrenia or major depression. Brain Res 1995; 681: 109–116.
Sher L, Mann JJ, Traskman-Bendz L, Winchel R, Huang YY, Fertuck E et al. Lower cerebrospinal fluid homovanillic acid levels in depressed suicide attempters. J Affect Disord 2006; 190: 83–89.
Walther DJ, Peter JU, Bashammakh S, Hortnagl H, Voits M, Fink H et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science 2003; 299: 76.
Zill P, Buttner A, Eisenmenger W, Bondy B, Ackenheil M . Regional mRNA expression of a second tryptophan hydroxylase isoform in postmortem tissue samples of two human brains. Eur Neuropsychopharmacol 2004; 14: 282–284.
Walther DJ, Bader M . A unique central tryptophan hydroxylase isoform. Biochem Pharmacol 2003; 66: 1673–1680.
Zill P, Buttner A, Eisenmenger W, Moller HJ, Ackenheil M, Bondy B . Analysis of tryptophan hydroxylase I and II mRNA expression in the human brain: A post-mortem study. J Psychiatr Res 2005; July 13 [Epub ahead of print].
Ono H, Shirakawa O, Kitamura N, Hashimoto T, Nishiguchi N, Nishimura A et al. Tryptophan hydroxylase immunoreactivity is altered by the genetic variation in postmortem brain samples of both suicide victims and controls. Mol Psychiatry 2002; 7: 1127–1132.
Bonkale WL, Murdock S, Janosky JE, Austin MC . Normal levels of tryptophan hydroxylase immunoreactivity in the dorsal raphe of depressed suicide victims. J Neurochem 2004; 88: 958–964.
Boldrini M, Underwood MD, Mann JJ, Arango V . More tryptophan hydroxylase in the brainstem dorsal raphe nucleus in depressed suicides. Brain Res 2005; 1041: 19–28.
Bach-Mizrachi H, Underwood MD, Kassir SA, Bakalian MJ, Sibille E, Tamir H et al. Neuronal tryptophan hydroxylase mRNA expression in the human dorsal and median raphe nuclei: major depression and suicide. Neuropsychopharmacology 2005; September 28 [Epub ahead of print].
De Luca V, Likhodi O, Van Tol HH, Kennedy JL, Wong DF . Gene expression of tryptophan hydroxylase 2 in post-mortem brain of suicide subjects. Int J Neuropsychopharmacol 2005; 8: 1–5.
Nielsen DA, Dean M, Goldman D . Genetic mapping of the human tryptophan hydroxylase gene on chromosome 11, using an intronic conformational polymorphism. Am J Hum Genet 1992; 51: 1366–1371.
Rotondo A, Schuebel K, Bergen A, Aragon R, Virkkunen M, Linnoila M et al. Identification of four variants in the tryptophan hydroxylase promoter and association to behavior. Mol Psychiatry 1999; 4: 360–368.
Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M . Suicidality and 5-hydroxyindoleacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry 1994; 51: 34–38.
Nielsen DA, Virkkunen M, Lappalainen J, Eggert M, Brown GL, Long JC et al. A tryptophan hydroxylase gene marker for suicidality and alcoholism. Arch Gen Psychiatry 1998; 55: 593–602.
Roy A, Rylander G, Forslund K, Asberg M, Mazzanti CM, Goldman D et al. Excess tryptophan hydroxylase 17 779C allele in surviving cotwins of monozygotic twin suicide victims. Neuropsychobiology 2001; 43: 233–236.
Mann JJ, Malone KM, Nielsen DA, Goldman D, Erdos J, Gelernter J . Possible association of a polymorphism of the tryptophan hydroxylase gene with suicidal behavior in depressed patients. Am J Psychiatry 1997; 154: 1451–1453.
Souery D, Van GS, Massat I, Blairy S, Adolfsson R, Blackwood D et al. Tryptophan hydroxylase polymorphism and suicidality in unipolar and bipolar affective disorders: a multicenter association study. Biol Psychiatry 2001; 49: 405–409.
Abbar M, Courtet P, Bellivier F, Leboyer M, Boulenger JP, Castelhau D et al. Suicide attempts and the tryptophan hydroxylase gene. Mol Psychiatry 2001; 6: 268–273.
Turecki G, Zhu D, Tzenova J, Lesage AD, Seguin M, Tousignant M et al. TPH and suicidal behaviour: a study in suicide completers. Mol Psychiatry 2001; 6: 98–102.
Manuck SB, Flory JD, Ferrell RE, Dent KM, Mann JJ, Muldoon MF . Aggression and anger-related traits associated with a polymorphism of the tryptophan hydroxylase gene. Biol Psychiatry 1999; 45: 603–614.
Rujescu D, Giegling I, Bondy B, Gietl A, Zill P, Moller HJ . Association of anger-related traits with SNPs in the TPH gene. Mol Psychiatry 2002; 7: 1023–1029.
Bennett PJ, McMahon WM, Watabe J, Achilles J, Bacon M, Coon H et al. Tryptophan hydroxylase polymorphisms in suicide victims. Psychiatr Genet 2000; 10: 13–17.
Du L, Faludi G, Palkovits M, Bakish D, Hrdina PD . Tryptophan hydroxylase gene 218A/C polymorphism is not associated with depressed suicide. Int J Neuropsychopharmacol 2000; 3: 215–220.
Stefulj J, Kubat M, Balija M, Skavic J, Jernej B . Variability of the tryptophan hydroxylase gene: study in victims of violent suicide. Psychiatry Res 2005; 134: 67–73.
Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y et al. Tryptophan hydroxylase gene polymorphisms are not associated with suicide. Am J Med Genet 2000; 96: 861–863.
Ohtani M, Shindo S, Yoshioka N . Polymorphisms of the tryptophan hydroxylase gene and serotonin 1A receptor gene in suicide victims among Japanese. Tohoku J Exp Med 2004; 202: 123–133.
Bellivier F, Leboyer M, Courtet P, Buresi C, Beaufils B, Samolyk D et al. Association between the tryptophan hydroxylase gene and manic-depressive illness. Arch Gen Psychiatry 1998; 55: 33–37.
Furlong RA, Ho L, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC . No association of the tryptophan hydroxylase gene with bipolar affective disorder, unipolar affective disorder, or suicidal behaviour in major affective disorder. Am J Med Genet 1998; 81: 245–247.
Koller G, Engel RR, Preuss UW, Karakesisoglou A, Zill P, Bondy B et al. Tryptophan hydroxylase gene 1 polymorphisms are not associated with suicide attempts in alcohol-dependent individuals. Addict Biol 2005; 10: 269–273.
Zalsman G, Frisch A, King RA, Pauls DL, Grice DE, Gelernter J et al. Case control and family-based studies of tryptophan hydroxylase gene A218C polymorphism and suicidality in adolescents. Am J Med Genet 2001; 105: 451–457.
Paik I, Toh K, Kim J, Lee C . TPH gene may be associated with suicidal behavior, but not with schizophrenia in the Korean population. Hum Hered 2000; 50: 365–369.
Tsai SJ, Hong CJ, Wang YC . Tryptophan hydroxylase gene polymorphism (A218C) and suicidal behaviors. Neuroreport 1999; 10: 3773–3775.
Kunugi H, Ishida S, Kato T, Sakai T, Tatsumi M, Hirose T et al. No evidence for an association of polymorphisms of the tryptophan hydroxylase gene with affective disorders or attempted suicide among Japanese patients. Am J Psychiatry 1999; 156: 774–776.
Lalovic A, Turecki G . Meta-analysis of the association between tryptophan hydroxylase and suicidal behavior. Am J Med Genet 2002; 114: 533–540.
Rujescu D, Giegling I, Sato T, Hartmann AM, Moller HJ . Genetic variations in tryptophan hydroxylase in suicidal behavior: analysis and meta-analysis. Biol Psychiatry 2003; 54: 465–473.
Bellivier F, Chaste P, Malafosse A . Association between the TPH gene A218C polymorphism and suicidal behavior: a meta-analysis. Am J Med Genet B Neuropsychiatr Genet 2004; 124: 87–91.
Zill P, Buttner A, Eisenmenger W, Moller HJ, Bondy B, Ackenheil M . Single nucleotide polymorphism and haplotype analysis of a novel tryptophan hydroxylase isoform (TPH2) gene in suicide victims. Biol Psychiatry 2004; 56: 581–586.
Kennedy MA, Miller AL, Rogers G, Luty S, Mulder R, Joyce P . Polymorphic variants and association analysis of TPH2, brain tryptophan hydroxylase. Neuropsychiatr Genet 2003; 122B: 69.
De Luca V, Voineskos D, Wong GW, Shinkai T, Rothe C, Strauss J et al. Promoter polymorphism of second tryptophan hydroxylase isoform (TPH2) in schizophrenia and suicidality. Psychiatry Res 2005; 134: 195–198.
Zhou Z, Roy A, Lipsky R, Kuchipudi K, Zhu G, Taubman J et al. Haplotype-based linkage of tryptophan hydroxylase 2 to suicide attempt, major depression, and cerebrospinal fluid 5-hydroxyindoleacetic acid in 4 populations. Arch Gen Psychiatry 2005; 62: 1109–1118.
Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D et al. Allelic variation of human serotonin transporter gene expression. J Neurochem 1996; 66: 2621–2624.
Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S et al. Association of anxiety-related traits with a polymorphism in the serotonin transporter gene regulatory region [see comments]. Science 1996; 274: 1527–1531.
Mann JJ, Huang YY, Underwood MD, Kassir SA, Oppenheim S, Kelly TM et al. A serotonin transporter gene promoter polymorphism (5-HTTLPR) and prefrontal cortical binding in major depression and suicide (see comments). Arch Gen Psychiatry 2000; 57: 729–738.
Preuss UW, Soyka M, Bahlmann M, Wenzel K, Behrens S, de Jonge S et al. Serotonin transporter gene regulatory region polymorphism (5-HTTLPR), [3H]paroxetine binding in healthy control subjects and alcohol-dependent patients and their relationships to impulsivity. Psychiatry Res 2000; 96: 51–61.
Bondy B, Erfurth A, de Jonge S, Kruger M, Meyer H . Possible association of the short allele of the serotonin transporter promoter gene polymorphism (5-HTTLPR) with violent suicide. Mol Psychiatry 2000; 5: 193–195.
Courtet P, Baud P, Abbar M, Boulenger JP, Castelnau D, Mouthon D et al. Association between violent suicidal behaviour and the low activity allele of the serotonin transporter gene. Mol Psychiatry 2001; 6: 338–341.
Fitch D, Lesage A, Seguin M, Trousignant M, Bankelfat C, Rouleau GA et al. Suicide and the serotonin transporter gene. Mol Psychiatry 2001; 6: 127–128.
Bellivier F, Szoke A, Henry C, Lacoste J, Bottos C, Nosten-Bertrand M et al. Possible association between serotonin transporter gene polymorphism and violent suicidal behavior in mood disorders. Biol Psychiatry 2000; 48: 319–322.
Bayle FJ, Leroy S, Gourion D, Millet B, Olie JP, Poirier MF et al. 5HTTLPR polymorphism in schizophrenic patients: further support for association with violent suicide attempts. Am J Med Genet B Neuropsychiatr Genet 2003; 119: 13–17.
Campi-Azevedo AC, Boson W, De ML, Romano-Silva MA, Correa H . Association of the serotonin transporter promoter polymorphism with suicidal behavior. Mol Psychiatry 2003; 8: 899–900.
Courtet P, Buresi C, Abbar M, Baud P, Boulenger JP, Castelnau D et al. No association between non-violent suicidal behavior and the serotonin transporter promoter polymorphism. Am J Med Genet 2003; 116B: 72–76.
Courtet P, Picot MC, Bellivier F, Torres S, Jollant F, Michelon C et al. Serotonin transporter gene may be involved in short-term risk of subsequent suicide attempts. Biol Psychiatry 2004; 55: 46–51.
Sander T, Harms H, Dufeu P, Kuhn S, Hoehe M, Lesch KP et al. Serotonin transporter gene variants in alcohol-dependent subjects with dissocial personality disorder. Biol Psychiatry 1998; 43: 908–912.
Gerra G, Garofano L, Santoro G, Bosari S, Pellegrini C, Zaimovic A et al. Association between low-activity serotonin transporter genotype and heroin dependence: behavioral and personality correlates. Am J Med Genet B Neuropsychiatr Genet 2004; 126: 37–42.
Gerra G, Garofano L, Castaldini L, Rovetto F, Zaimovic A, Moi G et al. Serotonin transporter promoter polymorphism genotype is associated with temperament, personality traits and illegal drugs use among adolescents. J Neural Transm 2005; 112: 1397–1410.
Baca-Garcia E, Vaquero C, az-Sastre C, Saiz-Ruiz J, Fernandez-Piqueras J, de LJ . A gender-specific association between the serotonin transporter gene and suicide attempts. Neuropsychopharmacology 2002; 26: 692–695.
Limosin F, Loze JY, Boni C, Hamon M, Ades J, Rouillon F et al. Male-specific association between the 5-HTTLPR S allele and suicide attempts in alcohol-dependent subjects. J Psychiatr Res 2005; 39: 179–182.
Gorwood P, Batel P, Ades J, Hamon M, Boni C . Serotonin transporter gene polymorphisms, alcoholism, and suicidal behavior. Biol Psychiatry 2000; 48: 259–264.
Preuss UW, Koller G, Soyka M, Bondy B . Association between suicide attempts and 5-HTTLPR-S-allele in alcohol-dependent and control subjects: further evidence from a German alcohol-dependent inpatient sample. Biol Psychiatry 2001; 50: 636–639.
Baca-Garcia E, Salgado BR, Segal HD, Lorenzo CV, Acosta MN, Romero MA et al. A pilot genetic study of the continuum between compulsivity and impulsivity in females: the serotonin transporter promoter polymorphism. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 713–717.
Rujescu D, Giegling I, Sato T, Moeller HJ . A polymorphism in the promoter of the serotonin transporter gene is not associated with suicidal behavior. Psychiatr Genet 2001; 11: 169–172.
Geijer T, Frisch A, Persson ML, Wasserman D, Rockah R, Michaelovsky E et al. Search for association between suicide attempt and serotonergic polymorphisms. Psychiatr Genet 2000; 10: 19–26.
Shen Y, Li H, Gu N, Tan Z, Tang J, Fan J et al. Relationship between suicidal behavior of psychotic inpatients and serotonin transporter gene in Han Chinese. Neurosci Lett 2004; 372: 94–98.
Chong SA, Lee WL, Tan CH, Tay AH, Chan AO, Tan EC . Attempted suicide and polymorphism of the serotonin transporter gene in Chinese patients with schizophrenia. Psychiatry Res 2000; 97: 101–106.
Zalsman G, Frisch A, Bromberg M, Gelernter J, Michaelovsky E, Campino A et al. Family-based association study of serotonin transporter promoter in suicidal adolescents: no association with suicidality but possible role in violence traits. Am J Med Genet 2001; 105: 239–245.
Russ MJ, Lachman HM, Kashdan T, Saito T, Bajmakovic-Kacila S . Analysis of catechol-O-methyltransferase and 5-hydroxytryptamine transporter polymorphisms in patients at risk for suicide. Psychiatry Res 2000; 93: 73–78.
Du L, Faludi G, Palkovits M, Demeter E, Bakish D, Lapierre YD et al. Frequency of long allele in serotonin transporter gene is increased in depressed suicide victims. Biol Psychiatry 1999; 46/2: 201.
Correa H, Campi-Azevedo AC, De ML, Boson W, Viana MM, Guimaraes MM et al. Familial suicide behaviour: association with probands suicide attempt characteristics and 5-HTTLPR polymorphism. Acta Psychiatr Scand 2004; 110: 459–464.
Joiner Jr TE, Johnson F, Soderstrom K . Association between serotonin transporter gene polymorphism and family history of attempted and completed suicide. Suicide Life Threat Behav 2002; 32: 329–332.
Anguelova M, Benkelfat C, Turecki G . A systematic review of association studies investigating genes coding for serotonin receptors and the serotonin transporter: I. Affective disorders. Mol Psychiatry 2003; 8: 574–591.
Lin PY, Tsai G . Association between serotonin transporter gene promoter polymorphism and suicide: results of a meta-analysis. Biol Psychiatry 2004; 55: 1023–1030.
De Luca V, Zai G, Tharmalingam S, de BA, Wong G, Kennedy JL . Association study between the novel functional polymorphism of the serotonin transporter gene and suicidal behaviour in schizophrenia. Eur Neuropsychopharmacol 2005; November 3 [Epub ahead of print].
de Lara CL, Dumais A, Rouleau G, Lesage A, Dumont M, Chawky N et al. STin2 variant and family history of suicide as significant predictors of suicide completion in major depression. Biol Psychiatry 2005; August 25 [Epub ahead of print].
Yen FC, Hong CJ, Hou SJ, Wang JK, Tsai SJ . Association study of serotonin transporter gene VNTR polymorphism and mood disorders, onset age and suicide attempts in a Chinese sample. Neuropsychobiology 2003; 48: 5–9.
Hranilovic D, Stefulj J, Furac I, Kubat M, Balija M, Jernej B . Serotonin transporter gene promoter (5-HTTLPR) and intron 2 (VNTR) polymorphisms in Croatian suicide victims. Biol Psychiatry 2003; 54: 884–889.
Turecki G, Briere R, Dewar K, Antonetti T, Lesage AD, Seguin M et al. Prediction of level of serotonin 2A receptor binding by serotonin receptor 2A genetic variation in postmortem brain samples from subjects who did or did not commit suicide. Am J Psychiatry 1999; 156: 1456–1458.
Oquendo MA, Russo SA, Underwood MD, Kassir SA, Ellis SP, Mann JJ et al. Higher postmortem prefrontal 5-HT(2A) receptor binding correlates with lifetime aggression in suicide. Biol Psychiatry 2005; Sep: 1.
Rao ML, Hawellek B, Papassotiropoulos A, Deister A, Frahnert C . Upregulation of the platelet Serotonin2A receptor and low blood serotonin in suicidal psychiatric patients. Neuropsychobiology 1998; 38: 84–89.
Alda M, Hrdina PD . Distribution of platelet 5-HT(2A) receptor densities in suicidal and non-suicidal depressives and control subjects. Psychiatry Res 2000; 94: 273–277.
Muller-Oerlinghausen B, Roggenbach J, Franke L . Serotonergic platelet markers of suicidal behavior – do they really exist? J Affect Disord 2004; 79: 13–24.
Norton N, Owen MJ . HTR2A: association and expression studies in neuropsychiatric genetics. Ann Med 2005; 37: 121–129.
Du L, Bakish D, Lapierre YD, Ravindran A, Hrdina P . Association of polymorphism of serotonin 2A receptor gene with suicidal ideation in major depressive disorder. Am J Med Genet Neuropsychiatric Genet 2000; 96: 56–60.
Arias B, Gasto C, Catalan R, Gutierrez B, Pintor L, Fananas L . The 5-HT(2A) receptor gene 102T/C polymorphism is associated with suicidal behavior in depressed patients. Am J Med Genet 2001; 105: 801–804.
Preuss UW, Koller G, Bahlmann M, Soyka M, Bondy B . No association between suicidal behavior and 5-HT2A-T102C polymorphism in alcohol dependents. Am J Med Genet 2000; 96: 877–878.
Ertugrul A, Kennedy JL, Masellis M, Basile VS, Jayathilake K, Meltzer HY . No association of the T102C polymorphism of the serotonin 2A receptor gene (HTR2A) with suicidality in schizophrenia. Schizophr Res 2004; 69: 301–305.
Tan EC, Chong SA, Chan AO, Tan CH . No evidence for association of the T102C polymorphism in the serotonin type 2A receptor with suicidal behavior in schizophrenia. Am J Med Genet 2002; 114: 321–322.
Khait VD, Huang YY, Zalsman G, Oquendo MA, Brent DA, Harkavy-Friedman JM et al. Association of serotonin 5-HT2A receptor binding and the T102C polymorphism in depressed and healthy Caucasian subjects. Neuropsychopharmacology 2005; 30: 166–172.
Correa H, De ML, Boson W, Viana MM, Lima VF, Campi-Azevedo AC et al. Analysis of T102C 5HT2A polymorphism in Brazilian psychiatric inpatients: relationship with suicidal behavior. Cell Mol Neurobiol 2002; 22: 813–817.
Bonnier B, Gorwood P, Hamon M, Sarfati Y, Boni C, Hardy-Bayle MC . Association of 5-HT(2A) receptor gene polymorphism with major affective disorders: the case of a subgroup of bipolar disorder with low suicide risk. Biol Psychiatry 2002; 51: 762–765.
Ohara K, Nagai M, Tsukamoto T, Tani K, Suzuki Y, Ohara K . 5-HT2A receptor gene promoter polymorphism – 1438G/A and mood disorders. Neuroreport 1998; 9: 1139–1141.
Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y et al. Serotonin 2A receptor gene polymorphism is not associated with completed suicide. J Psychiatr Res 2001; 35: 173–176.
Bondy B, Kuznik J, Baghai T, Schule C, Zwanzger P, Minov C et al. Lack of association of serotonin-2A receptor gene polymorphism (T102C) with suicidal ideation and suicide. Am J Med Genet Neuropsychiatr Genet 2000; 96/6: 835.
Crawford J, Sutherland GR, Goldney RD . No evidence for association of 5-HT2A receptor polymorphism with suicide. Am J Med Genet 2000; 96: 879–880.
Albert PR, Lembo P, Storring JM, Charest A, Saucier C . The 5-HT1A receptor: signaling, desensitization, and gene transcription. Neuropsychopharmacology 1996; 14: 19–25.
Stockmeier CA, Shapiro LA, Dilley GE, Kolli TN, Friedman L, Rajkowska G . Increase in serotonin-1A autoreceptors in the midbrain of suicide victims with major depression-postmortem evidence for decreased serotonin activity. J Neurosci 1998; 18: 7394–7401.
Huang YY, Battistuzzi C, Oquendo MA, Harkavy-Friedman J, Greenhill L, Zalsman G et al. Human 5-HT1A receptor C(−1019)G polymorphism and psychopathology. Int J Neuropsychopharmacol 2004; 7: 441–451.
Lemonde S, Turecki G, Bakish D, Du L, Hrdina PD, Bown CD et al. Impaired repression at a 5-hydroxytryptamine 1A receptor gene polymorphism associated with major depression and suicide. J Neurosci 2003; 23: 8788–8799.
Albert PR, Lemonde S . 5-HT1A receptors, gene repression, and depression: guilt by association. Neuroscientist 2004; 10: 575–593.
Lemonde S, Du L, Bakish D, Hrdina P, Albert PR . Association of the C(−1019)G 5-HT1A functional promoter polymorphism with antidepressant response. Int J Neuropsychopharmacol 2004; 7: 501–506.
Nishiguchi N, Shirakawa O, Ono H, Nishimura A, Nushida H, Ueno Y et al. Lack of an association between 5-HT1A receptor gene structural polymorphisms and suicide victims. Am J Med Genet 2002; 114: 423–425.
Lappalainen J, Long JC, Eggert M, Ozaki N, Robin RW, Brown GL et al. Linkage of antisocial alcoholism to the serotonin 5-HT1B receptor gene in 2 populations. Arch Gen Psychiatry 1998; 55: 989–994.
Soyka M, Preuss UW, Koller G, Zill P, Bondy B . Association of 5-HT1B receptor gene and antisocial behavior in alcoholism. J Neural Transm 2004; 111: 101–109.
Huang YY, Grailhe R, Arango V, Hen R, Mann JJ . Relationship of psychopathology to the human serotonin1B genotype and receptor binding kinetics in postmortem brain tissue. Neuropsychopharmacology 1999; 21: 238–246.
Rujescu D, Giegling I, Sato T, Moller HJ . Lack of association between serotonin 5-HT1B receptor gene polymorphism and suicidal behavior. Am J Med Genet B Neuropsychiatr Genet 2003; 116: 69–71.
Stefulj J, Buttner A, Skavic J, Zill P, Balija M, Eisenmenger W et al. Serotonin 1B (5HT-1B) receptor polymorphism (G861C) in suicide victims: association studies in German and Slavic population. Am J Med Genet B Neuropsychiatr Genet 2004; 127: 48–50.
Nishiguchi N, Shirakawa O, Ono H, Nishimura A, Nushida H, Ueno Y et al. No evidence of an association between 5HT1B receptor gene polymorphism and suicide victims in a Japanese population. Am J Med Genet 2001; 105: 343–345.
Sanders AR, Duan J, Gejman PV . DNA variation and psychopharmacology of the human serotonin receptor 1B (HTR1B) gene. Pharmacogenomics 2002; 3: 745–762.
Hong CJ, Pan GM, Tsai SJ . Association study of onset age, attempted suicide, aggressive behavior, and schizophrenia with a serotonin 1B receptor (A-161T) genetic polymorphism. Neuropsychobiology 2004; 49: 1–4.
Tsai SJ, Hong CJ, Yu YW, Chen TJ, Wang YC, Lin WK . Association study of serotonin 1B receptor (A-161T) genetic polymorphism and suicidal behaviors and response to fluoxetine in major depressive disorder. Neuropsychobiology 2004; 50: 235–238.
Stefulj J, Buttner A, Kubat M, Zill P, Balija M, Eisenmenger W et al. 5HT-2C receptor polymorphism in suicide victims. Association studies in German and Slavic populations. Eur Arch Psychiatry Clin Neurosci 2004; 254: 224–227.
Okamura K, Shirakawa O, Nishiguchi N, Ono H, Nushida H, Ueno Y et al. Lack of an association between 5-HT receptor gene polymorphisms and suicide victims. Psychiatry Clin Neurosci 2005; 59: 345–349.
Turecki G, Sequeira A, Gingras Y, Seguin M, Lesage A, Tousignant M et al. Suicide and serotonin: study of variation at seven serotonin receptor genes in suicide completers. Am J Med Genet B Neuropsychiatr Genet 2003; 118: 36–40.
Charney DS . Monoamine dysfunction and the pathophysiology and treatment of depression. J Clin Psychiatry 1998; 59 (Suppl 14): 11–14.
Polymeropoulos MH, Xiao H, Rath DS, Merril CR . Tetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH). Nucleic Acids Res 1991; 19: 3753.
Persson ML, Wasserman D, Geijer T, Jonsson EG, Terenius L . Tyrosine hydroxylase allelic distribution in suicide attempters. Psychiatry Res 1997; 72: 73–80.
Ma J, Yoshimura M, Yamashita E, Nakagawa A, Ito A, Tsukihara T . Structure of rat monoamine oxidase A and its specific recognitions for substrates and inhibitors. J Mol Biol 2004; 338: 103–114.
Schalling D, Asberg M, Edman G, Oreland L . Markers for vulnerability to psychopathology: temperament traits associated with platelet MAO activity. Acta Psychiatr Scand 1987; 76: 172–182.
Skondras M, Markianos M, Botsis A, Bistolaki E, Christodoulou G . Platelet monoamine oxidase activity and psychometric correlates in male violent offenders imprisoned for homicide or other violent acts. Eur Arch Psychiatry Clin Neurosci 2004; 254: 380–386.
Brunner HG, Nelen MR, van Zandvoort P, Abeling NG, van Gennip AH, Wolters EC et al. X-linked borderline mental retardation with prominent behavioral disturbance: phenotype, genetic localization, and evidence for disturbed monoamine metabolism [see comments]. Am J Hum Genet 1993; 52: 1032–1039.
Sabol SZ, Hu S, Hamer D . A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 1998; 103: 273–279.
Hotamisligil GS, Breakefield XO . Human monoamine oxidase A gene determines levels of enzyme activity. Am J Hum Genet 1991; 49: 383–392.
Manuck SB, Flory JD, Ferrell RE, Mann JJ, Muldoon MF . A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res 2000; 95: 9–23.
Garpenstrand H, Norton N, Damberg M, Rylander G, Forslund K, Mattila-Evenden M et al. A regulatory monoamine oxidase a promoter polymorphism and personality traits. Neuropsychobiology 2002; 46: 190–193.
Jonsson EG, Norton N, Gustavsson JP, Oreland L, Owen MJ, Sedvall GC . A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers. J Psychiatr Res 2000; 34: 239–244.
Williams RB, Marchuk DA, Gadde KM, Barefoot JC, Grichnik K, Helms MJ et al. Serotonin-related gene polymorphisms and central nervous system serotonin function. Neuropsychopharmacology 2003; 28: 533–541.
Hattori E, Liu C, Zhu H, Gershon ES . Genetic tests of biologic systems in affective disorders. Mol Psychiatry 2005; 10: 719–740.
Ho LW, Furlong RA, Rubinsztein JS, Walsh C, Paykel ES, Rubinsztein DC . Genetic associations with clinical characteristics in bipolar affective disorder and recurrent unipolar depressive disorder. Am J Med Genet 2000; 96: 36–42.
Gerra G, Garofano L, Bosari S, Pellegrini C, Zaimovic A, Moi G et al. Analysis of monoamine oxidase A (MAO-A) promoter polymorphism in male heroin-dependent subjects: behavioural and personality correlates. J Neural Transm 2004; 111: 611–621.
Kunugi H, Ishida S, Kato T, Tatsumi M, Sakai T, Hattori M et al. A functional polymorphism in the promoter region of monoamine oxidase-A gene and mood disorders. Mol Psychiatry 1999; 4: 393–395.
Ono H, Shirakawa O, Nishiguchi N, Nishimura A, Nushida H, Ueno Y et al. No evidence of an association between a functional monoamine oxidase a gene polymorphism and completed suicides. Am J Med Genet 2002; 114: 340–342.
Du L, Faludi G, Palkovits M, Sotonyi P, Bakish D, Hrdina PD . High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport 2002; 13: 1195–1198.
Courtet P, Jollant F, Buresi C, Castelnau D, Mouthon D, Malafosse A . The monoamine oxidase A gene may influence the means used in suicide attempts. Psychiatr Genet 2005; 15: 189–193.
Ordway GA . Pathophysiology of the locus coeruleus in suicide. Ann NY Acad Sci 1997; 836: 233–252.
Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM . Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996; 6: 243–250.
Koen L, Kinnear CJ, Corfield VA, Emsley RA, Jordaan E, Keyter N et al. Violence in male patients with schizophrenia: risk markers in a South African population. Aust NZ J Psychiatry 2004; 38: 254–259.
Strous RD, Nolan KA, Lapidus R, Diaz L, Saito T, Lachman HM . Aggressive behavior in schizophrenia is associated with the low enzyme activity COMT polymorphism: a replication study. Am J Med Genet B Neuropsychiatr Genet 2003; 120: 29–34.
Kotler M, Barak P, Cohen H, Averbuch IE, Grinshpoon A, Gritsenko I et al. Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol-O-methyltransferase (COMT) activity. Am J Med Genet 1999; 88: 628–633.
Liou YJ, Tsai SJ, Hong CJ, Wang YC, Lai IC . Association analysis of a functional catechol-O-methyltransferase gene polymorphism in schizophrenic patients in Taiwan. Neuropsychobiology 2001; 43: 11–14.
Nolan KA, Volavka J, Czobor P, Cseh A, Lachman H, Saito T et al. Suicidal behavior in patients with schizophrenia is related to COMT polymorphism. Psychiatr Genet 2000; 10: 117–124.
Ono H, Shirakawa O, Nushida H, Ueno Y, Maeda K . Association between catechol-O-methyltransferase functional polymorphism and male suicide completers. Neuropsychopharmacology 2004; 29: 1374–1377.
De Luca V, Tharmalingam S, Sicard T, Kennedy JL . Gene-gene interaction between MAOA and COMT in suicidal behavior. Neurosci Lett 2005; 383: 151–154.
Franken IH, Booij J, van den BW . The role of dopamine in human addiction: from reward to motivated attention. Eur J Pharmacol 2005; 526: 199–206.
Bowirrat A, Oscar-Berman M . Relationship between dopaminergic neurotransmission, alcoholism, and Reward Deficiency syndrome. Am J Med Genet B Neuropsychiatr Genet 2005; 132: 29–37.
Noble EP . D2 dopamine receptor gene in psychiatric and neurologic disorders and its phenotypes. Am J Med Genet B Neuropsychiatr Genet 2003; 116: 103–125.
Arinami T, Gao M, Hamaguchi H, Toru M . A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997; 6: 577–582.
Johann M, Putzhammer A, Eichhammer P, Wodarz N . Association of the −141C Del variant of the dopamine D2 receptor (DRD2) with positive family history and suicidality in German alcoholics. Am J Med Genet B Neuropsychiatr Genet 2005; 132: 46–49.
Kluger J . Medicating young minds. Time 2003; 162: 46–48, 58.
Zalsman G, Frisch A, Lewis R, Michaelovsky E, Hermesh H, Sher L et al. DRD4 receptor gene exon III polymorphism in inpatient suicidal adolescents. J Neural Transm 2004; 111: 1593–1603.
Persson ML, Geijer T, Wasserman D, Rockah R, Frisch A, Michaelovsky E et al. Lack of association between suicide attempt and a polymorphism at the dopamine receptor D4 locus. Psychiatr Genet 1999; 9: 97–100.
Sequeira A, Mamdani F, Lalovic A, Anguelova M, Lesage A, Seguin M et al. Alpha 2A adrenergic receptor gene and suicide. Psychiatry Res 2004; 125: 87–93.
Viveros MP, Marco EM, File SE . Endocannabinoid system and stress and anxiety responses. Pharmacol Biochem Behav 2005; 81: 331–342.
Hungund BL, Vinod KY, Kassir SA, Basavarajappa BS, Yalamanchili R, Cooper TB et al. Upregulation of CB1 receptors and agonist-stimulated [35S]GTPgammaS binding in the prefrontal cortex of depressed suicide victims. Mol Psychiatry 2004; 9: 184–190.
Baca-Garcia E, Vaquero C, az-Sastre C, Garcia-Resa E, Saiz-Ruiz J, Fernandez-Piqueras J et al. Lack of association between the serotonin transporter promoter gene polymorphism and impulsivity or aggressive behavior among suicide attempters and healthy volunteers. Psychiatry Res 2004; 126: 99–106.
Shindo S, Yoshioka N . Polymorphisms of the cholecystokinin gene promoter region in suicide victims in Japan. Forensic Sci Int 2005; 150: 85–90.
Dwivedi Y, Rizavi HS, Conley RR, Roberts RC, Tamminga CA, Pandey GN . Altered gene expression of brain-derived neurotrophic factor and receptor tyrosine kinase B in postmortem brain of suicide subjects. Arch Gen Psychiatry 2003; 60: 804–815.
Hong CJ, Huo SJ, Yen FC, Tung CL, Pan GM, Tsai SJ . Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 2003; 48: 186–189.
Kunugi H, Hashimoto R, Yoshida M, Tatsumi M, Kamijima K . A missense polymorphism (S205L) of the low-affinity neurotrophin receptor p75NTR gene is associated with depressive disorder and attempted suicide. Am J Med Genet B Neuropsychiatr Genet 2004; 129: 44–46.
Yanagi M, Shirakawa O, Kitamura N, Okamura K, Sakurai K, Nishiguchi N et al. Association of 14-3-3 epsilon gene haplotype with completed suicide in Japanese. J Hum Genet 2005; 50: 210–216.
Bunney WE, Bunney BG, Vawter MP, Tomita H, Li J, Evans SJ et al. Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. Am J Psychiatry 2003; 160: 657–666.
Gwadry FG, Sequeira A, Hoke G, Ffrench-Mullen JM, Turecki G . Molecular characterization of suicide by microarray analysis. Am J Med Genet C Semin Med Genet 2005; 133: 48–56.
Detera-Wadleigh SD, McMahon FJ . Genetic association studies in mood disorders: issues and promise. Int Rev Psychiatry 2004; 16: 301–310.
Serretti A, Artioli P . The pharmacogenomics of selective serotonin reuptake inhibitors. Pharmacogenomics J 2004; 4: 233–244.
Risch N, Merikangas K . The future of genetic studies of complex human diseases. Science 1996; 273: 1516–1517.
Mann JJ . Psychobiologic predictors of suicide. J Clin Psychiatry 1987; 48 (Suppl): 39–43.
Brent DA, Bridge J, Johnson BA, Connolly J . Suicidal behavior runs in families. A controlled family study of adolescent suicide victims. Arch Gen Psychiatry 1996; 53: 1145–1152.
Balazic J, Marusic A . The completed suicide as interplay of genes and environment. Forensic Sci Int 2005; 147 (Suppl): S1–S3.
Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science 2003; 301: 386–389.
Acknowledgements
A part of the work cited here was supported by the German Federal Research Ministry within the promotional emphasis Competence Nets in Medicine.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bondy, B., Buettner, A. & Zill, P. Genetics of suicide. Mol Psychiatry 11, 336–351 (2006). https://doi.org/10.1038/sj.mp.4001803
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.mp.4001803
Keywords
This article is cited by
-
Dissecting the genetic architecture of suicide attempt and repeated attempts in Korean patients with bipolar disorder using polygenic risk scores
International Journal of Bipolar Disorders (2022)
-
The intergenerational transmission of suicidal behavior: an offspring of siblings study
Translational Psychiatry (2020)
-
Prenatal Stress, Maternal Immune Dysregulation, and Their Association With Autism Spectrum Disorders
Current Psychiatry Reports (2018)
-
Association Study of VMAT1 Polymorphisms and Suicide Behavior
Journal of Molecular Neuroscience (2018)